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Risk assessment of nanomaterials repre-
sents one of the cutting-edge topics in toxi-
cology (Zhao et al., 2014; Lucafo et al., 
2013; Fadeel et al., 2013; Kroll et al., 2012; 
Kim et al., 2012; Hadrup et al., 2012; Lange 
and Obendorf, 2012; Xu et al., 2013). Nu-
merous nanomaterial containing consumer 
products have already been introduced on the 
market, including textiles, sunscreens, paints, 
car tyres and electronics (Bolt et al., 2012; 
Kumar and Dhawan, 2013; Schluesener and 
Schluesener, 2013; Marchan, 2012). The 
number of manuscripts published in this field 
is high, with more 500 publications focusing 
on nanosafety-associated topics per year 
(Bolt et al., 2012; Schäfer et al., 2013; Horie 
et al., 2013; Klein et al., 2012; Hoelting et 
al., 2013; Silva et al., 2014). It has become 
clear that a detailed physical and chemical 
characterization of nanomaterials is required 
for risk evaluation (Park et al., 2013; Xiong 
et al., 2013; Zhao et al., 2013; Couto et al., 
2014). Among the current challenges are the 
methodological requirements in exposure 
monitoring (Babič et al., 2014; Lainé et al., 
2014; Su et al., 2014; Bruchet et al., 2013). 
Because of the enormous variability and the 
rapid development of novel materials it has 
become difficult for regulators to keep pace 
and maintain overview. In this complex situ-
ation the Advisory Board of the German So-
ciety of Toxicology introduced the Gebel-
criteria, a novel concept of risk assessment in 
nanotoxicology (Gebel et al., 2014). Accord-
ing to this concept, a first step in evaluating 
novel nanomaterials should be to check 
whether they belong to one of the three fol-
lowing categories: Category 1: Nanoparticles 
for which toxicity is mediated by the specific 
chemical properties of its components, such 
as relaxed ions. Nanomaterials belonging to 
this category must be evaluated on a case-by-
case basis. Category 2 are rigid biopersistent 
respirable fibrous nanomaterials. They may 
cause lung cancer and mesotheliomas, if they 
show a high aspect ratio. In this case they 
will act similarly as carcinogenic asbestos 
fibres. Category 3 are respirable granular 
biodurable particles. After inhalation they 
may cause inflammation and finally lung 
cancer. It should be considered that nano-
materials of categories 2 and 3 are of rele-
vance only after inhalation (Gebel et al., 
2014). Considering the complex situation in 
current nanotoxicology the introduction of 
the three ‘Gebel-criteria’ will facilitate risk 
assessment in future. 
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